(1)
DETERMINATION OF ATORVASTATINE IN PHARMACEUTICAL FORMULATIONS BY REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. Int J of Adv in Phar Ana 2012, 2 (2), 47-52. https://doi.org/10.7439/ijapa.v2i2.19.